This inventor holds 17 USPTO granted patents, primarily in Immunotherapy Research. Top assignee: Fordham University. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Akron, OH (US) (1999 - 2002)
- Mineola, NY (US) (2000 - 2002)
Company Filing History:
Years Active: 1999-2002
Areas of Expertise:
Title: Innovations of Rajiv Y Chandawarkar
Introduction
Rajiv Y Chandawarkar is a prominent inventor based in Mineola, NY (US). He has made significant contributions to the field of tissue repair and cancer treatment through his innovative patents. With a total of 17 patents to his name, his work has the potential to impact medical science profoundly.
Latest Patents
Chandawarkar's latest patents include compositions and methods for promoting tissue repair using heat shock proteins. This invention relates to methods and compositions that promote tissue repair, specifically through the use of heat shock proteins such as gp96, hsp90, and hsp70. These proteins can be administered in various therapeutic methods to aid in the repair of tissues disrupted by trauma or disease. Another notable patent focuses on the prevention of primary and metastatic neoplastic diseases using hsp70-peptide complexes. This invention outlines methods for eliciting an immune response to prevent and treat neoplastic and infectious diseases through the administration of heat shock protein complexes.
Career Highlights
Chandawarkar is affiliated with Fordham University, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in regenerative medicine and oncology.
Collaborations
Chandawarkar collaborates with Pramod K Srivastava, enhancing the scope and impact of their research endeavors.
Conclusion
Rajiv Y Chandawarkar's contributions to the fields of tissue repair and cancer treatment through his innovative patents highlight his role as a leading inventor. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
